Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape

Abstract This report describes the successful transition of two familial patients with HAE from injectable to oral prophylaxis without tapering prior therapy or employing a complex transition protocol.

Guardado en:

Detalles Bibliográficos
Autores principales:	Daniel F. Soteres, Fellicia Grimes
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	berotralstat Haegarda hereditary angioedema shared decision‐making switching treatment burden Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9f9b6dc585b9445e847dbdd2d0e4219d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9f9b6dc585b9445e847dbdd2d0e4219d
record_format	dspace
spelling	oai:doaj.org-article:9f9b6dc585b9445e847dbdd2d0e4219d2021-12-01T06:36:08ZPatient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape2050-090410.1002/ccr3.5086https://doaj.org/article/9f9b6dc585b9445e847dbdd2d0e4219d2021-11-01T00:00:00Zhttps://doi.org/10.1002/ccr3.5086https://doaj.org/toc/2050-0904Abstract This report describes the successful transition of two familial patients with HAE from injectable to oral prophylaxis without tapering prior therapy or employing a complex transition protocol.Daniel F. SoteresFellicia GrimesWileyarticleberotralstatHaegardahereditary angioedemashared decision‐makingswitchingtreatment burdenMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	berotralstat Haegarda hereditary angioedema shared decision‐making switching treatment burden Medicine R Medicine (General) R5-920
spellingShingle	berotralstat Haegarda hereditary angioedema shared decision‐making switching treatment burden Medicine R Medicine (General) R5-920 Daniel F. Soteres Fellicia Grimes Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
description	Abstract This report describes the successful transition of two familial patients with HAE from injectable to oral prophylaxis without tapering prior therapy or employing a complex transition protocol.
format	article
author	Daniel F. Soteres Fellicia Grimes
author_facet	Daniel F. Soteres Fellicia Grimes
author_sort	Daniel F. Soteres
title	Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
title_short	Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
title_full	Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
title_fullStr	Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
title_full_unstemmed	Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
title_sort	patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/9f9b6dc585b9445e847dbdd2d0e4219d
work_keys_str_mv	AT danielfsoteres patientandcaregiverperspectivesontransitioningtooralprophylaxisintheemerginghereditaryangioedematreatmentlandscape AT felliciagrimes patientandcaregiverperspectivesontransitioningtooralprophylaxisintheemerginghereditaryangioedematreatmentlandscape
_version_	1718405494030204928

Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape

Ejemplares similares